250 related articles for article (PubMed ID: 38672505)
21. Thrombopoietin and hematopoietic stem cell development.
Kaushansky K
Ann N Y Acad Sci; 1999 Apr; 872():314-9. PubMed ID: 10372133
[TBL] [Abstract][Full Text] [Related]
22. [Significance of thrombopoietin and its receptor c-Mpl in regulation of thrombocytopoiesis in thrombocytopenia].
Strauss G; Ballmaier M; Schulze H; Bogenberger J; Riehm H; Welte K
Klin Padiatr; 1996; 208(4):168-71. PubMed ID: 8926683
[TBL] [Abstract][Full Text] [Related]
23. Thrombopoiesis: new concepts.
van Geet C
Verh K Acad Geneeskd Belg; 2004; 66(1):5-24; discussion 24-7. PubMed ID: 15074080
[TBL] [Abstract][Full Text] [Related]
24. OP9 bone marrow stroma cells differentiate into megakaryocytes and platelets.
Matsubara Y; Ono Y; Suzuki H; Arai F; Suda T; Murata M; Ikeda Y
PLoS One; 2013; 8(3):e58123. PubMed ID: 23469264
[TBL] [Abstract][Full Text] [Related]
25. Two patterns of thrombopoietin signaling suggest no coupling between platelet production and thrombopoietin reactivity in thrombocytopenia-absent radii syndrome.
Fiedler J; Strauss G; Wannack M; Schwiebert S; Seidel K; Henning K; Klopocki E; Schmugge M; Gaedicke G; Schulze H
Haematologica; 2012 Jan; 97(1):73-81. PubMed ID: 21933853
[TBL] [Abstract][Full Text] [Related]
26. JAK2V617F Megakaryocytes Promote Hematopoietic Stem/Progenitor Cell Expansion in Mice Through Thrombopoietin/MPL Signaling.
Zhang Y; Lin CHS; Kaushansky K; Zhan H
Stem Cells; 2018 Nov; 36(11):1676-1684. PubMed ID: 30005133
[TBL] [Abstract][Full Text] [Related]
27. [Clinical use of thrombopoietin (c-Mpl Ligand)].
Borota R; Borota J; Belić A; Gebauer E; Stefanović N
Med Pregl; 1998; 51(11-12):501-8. PubMed ID: 10081270
[TBL] [Abstract][Full Text] [Related]
28. The end is just the beginning: megakaryocyte apoptosis and platelet release.
Li J; Kuter DJ
Int J Hematol; 2001 Dec; 74(4):365-74. PubMed ID: 11794690
[TBL] [Abstract][Full Text] [Related]
29. Thrombopoietin in vitro and in vivo.
Alexander WS; Begley CG
Cytokines Cell Mol Ther; 1998 Mar; 4(1):25-34. PubMed ID: 9557214
[TBL] [Abstract][Full Text] [Related]
30. Incomplete restoration of Mpl expression in the mpl-/- mouse produces partial correction of the stem cell-repopulating defect and paradoxical thrombocytosis.
Lannutti BJ; Epp A; Roy J; Chen J; Josephson NC
Blood; 2009 Feb; 113(8):1778-85. PubMed ID: 18796624
[TBL] [Abstract][Full Text] [Related]
31. H2S protects against fatal myelosuppression by promoting the generation of megakaryocytes/platelets.
Liu HD; Zhang AJ; Xu JJ; Chen Y; Zhu YC
J Hematol Oncol; 2016 Feb; 9():13. PubMed ID: 26912146
[TBL] [Abstract][Full Text] [Related]
32. Pathophysiology and management of thrombocytopenia in bone marrow failure: possible clinical applications of TPO receptor agonists in aplastic anemia and myelodysplastic syndromes.
Townsley DM; Desmond R; Dunbar CE; Young NS
Int J Hematol; 2013 Jul; 98(1):48-55. PubMed ID: 23690288
[TBL] [Abstract][Full Text] [Related]
33. Humanized VB22B minibody for human Mpl stimulates human megakaryopoiesis but does not enhance platelet aggregation.
Matsuki E; Miyakawa Y; Yamane A; Okamoto S
Exp Hematol; 2011 Aug; 39(8):829-36. PubMed ID: 21605620
[TBL] [Abstract][Full Text] [Related]
34. Advances in megakaryocytopoiesis and thrombopoiesis: from bench to bedside.
Deutsch VR; Tomer A
Br J Haematol; 2013 Jun; 161(6):778-93. PubMed ID: 23594368
[TBL] [Abstract][Full Text] [Related]
35. Stimulation of megakaryocyte and platelet production by a single dose of recombinant human thrombopoietin in patients with cancer.
Vadhan-Raj S; Murray LJ; Bueso-Ramos C; Patel S; Reddy SP; Hoots WK; Johnston T; Papadopolous NE; Hittelman WN; Johnston DA; Yang TA; Paton VE; Cohen RL; Hellmann SD; Benjamin RS; Broxmeyer HE
Ann Intern Med; 1997 May; 126(9):673-81. PubMed ID: 9139552
[TBL] [Abstract][Full Text] [Related]
36. Human adipose tissue-derived stromal cells can differentiate into megakaryocytes and platelets by secreting endogenous thrombopoietin.
Ono-Uruga Y; Tozawa K; Horiuchi T; Murata M; Okamoto S; Ikeda Y; Suda T; Matsubara Y
J Thromb Haemost; 2016 Jun; 14(6):1285-97. PubMed ID: 26990635
[TBL] [Abstract][Full Text] [Related]
37. Thrombopoiesis.
Kaushansky K
Semin Hematol; 2015 Jan; 52(1):4-11. PubMed ID: 25578413
[TBL] [Abstract][Full Text] [Related]
38. Chemokine-mediated interaction of hematopoietic progenitors with the bone marrow vascular niche is required for thrombopoiesis.
Avecilla ST; Hattori K; Heissig B; Tejada R; Liao F; Shido K; Jin DK; Dias S; Zhang F; Hartman TE; Hackett NR; Crystal RG; Witte L; Hicklin DJ; Bohlen P; Eaton D; Lyden D; de Sauvage F; Rafii S
Nat Med; 2004 Jan; 10(1):64-71. PubMed ID: 14702636
[TBL] [Abstract][Full Text] [Related]
39. Pronounced thrombocytosis in transgenic mice expressing reduced levels of Mpl in platelets and terminally differentiated megakaryocytes.
Tiedt R; Coers J; Ziegler S; Wiestner A; Hao-Shen H; Bornmann C; Schenkel J; Karakhanova S; de Sauvage FJ; Jackson CW; Skoda RC
Blood; 2009 Feb; 113(8):1768-77. PubMed ID: 18845793
[TBL] [Abstract][Full Text] [Related]
40. New insights into the regulation of megakaryocyte differentiation and platelet production derived from cloning of thrombopoietin and its receptor: surprises and unresolved questions as thrombopoietin proceeds through clinical trials.
Jackson CW
J Lab Clin Med; 1998 Jun; 131(6):480-4. PubMed ID: 9626981
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
